Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Polyneuropathies 1Polycystic Ovary Syndrome 1Neoplasms 1Multiple Myeloma 1Mucositis 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Hematologic Neoplasms 1Glioma 1Frailty 1Fanconi Anemia 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Geriatric Assessment 10epigallocatechin gallate 2Preoperative Exercise 2Nutritional Support 2Nutrition Assessment 2Exercise 2Ascorbic Acid 2peflavit 1microcrystalline cellulose 1fisetin 1diacetamate 1cabozantinib 1Tretinoin 1Therapeutics 1Temozolomide 1Standard of Care 1Restraint, Physical 1Resistance Training 1Quercetin 1Qigong 1Psychosocial Intervention 1Protons 1Photons 1Methods 1Immunonutrition Diet 1Flavonoids 1Enhanced Recovery After Surgery 1Dasatinib 1Control Groups 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Frailty × Quercetin × Clear all
NCT04733534 2026-04-24

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
110 enrolled

Frailty, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡